News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

yourDigitalLab Announces Inaugural Digital Growth Summit Featuring Celebrated Economist & Retirement Guru Tom Hegna

AmeriLife

yourDigitalLab (YDL) – a nationally recognized digital marketing agency specifically servicing wealth advisors, insurance agents and independent marketing organizations (IMOs) – announced today the agenda for its highly anticipated Digital Growth Summit. Its focus: charting the course to navigate the complex digital marketing ecosystem. The summit is taking place virtually on Wednesday, July 26, and will feature a special guest appearance by noted economist, author and retirement expert Tom Hegna, who will also help introduce YDL’s newest digital marketing offerings for wealth advisors, all with one goal in mind: helping attendees drive real growth. “YDL is excited to host our first virtual summit showcasing how the various digital channels can be used by agents and advisors to strengthen their current sales strategies and introduce new tactics to grow their book of business” said JoAnna Barker, head of strategy and business development for yourDigitalLab. “This summit is for every agent and advisor in the life, health, annuities and financial services space who is interested in dominating their results from the previous year.” “I’m really excited about what yourDigitalLab is doing with its digital offerings, especially to help agents sell a broader suite of products such as annuities,” added Hegna. “One of the biggest reasons they often don’t is a lack of confidence and understanding of the products. Together with yourDigitalLab, I look forward to helping them fix that. We’ll show them the ‘math and science’ behind the selling and how adding these products – supported by the right digital marketing strategies – can increase their clients’ success in retirement.” Over the course of the day, attendees will have access to a variety of educational and thought-provoking sessions that will leave them with practical knowledge and a greater understand of the digital landscape that they must navigate today. Sessions will include: Tom Hegna on “10 Ways to Stand Out in 2023” Building Your Personal Brand Bringing Your Brand to Life – Website, Podcast and Radio, and More All About Email Marketing Driving Leads with Social and Video Launched in January 2023, yourDigitalLab has been at the forefront of digital marketing for the modern health and wealth agent and advisor, offering bespoke and pre-packaged services designed to drive more qualified leads and elevate its clients’ online brand presence. A full-service agency – created in partnership with AmeriLife for its national distribution network of more than 70 companies and their agents and advisors – YDL is a one-of-kind solution that combines deep expertise in modern marketing practices with extensive knowledge of the Medicare and wealth business, recruitment and regulatory landscape. “The Digital Growth Summit is an incredible opportunity to bring together Tom’s expertise and prestige in the retirement space with the proven capabilities of a premier agency such as yourDigitalLab,” said Ovi Vitas, Chief Marketing Officer for AmeriLife. “This event will undoubtedly be a gamechanger for attendees and help further cement AmeriLife and its family of companies as the partner of choice for agents and advisors nationwide.” To register for the Digital Growth Summit, click here. ### About yourDigitalLab yourDigitalLab (YDL) is a leading full-service digital marketing agency that was created exclusively for insurance agents and financial advisors with a focus on speed, cost and quality. For five years, YDL have been working to optimize various marketing campaigns designed to deliver the results agents and advisors want. YDL is the trusted choice for agents and advisors looking to drive sales and leads with modern, proven online marketing strategies. For more information about YDL or to schedule a consultation, visit yourDigitalLab.com. About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and 120 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details Media Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

April 24, 2023 01:00 PM Eastern Daylight Time

Article thumbnail News Release

Surgalign reveals renewed emphasis of artificial intelligence to treat spinal conditions

Surgalign Holdings

Surgalign President and CEO Terry Rich joins Proactive's Natalie Stoberman to discuss the company's focus on artificial intelligence and treating spinal injuries and degenerative conditions. Surgalign Holdings is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

April 24, 2023 12:57 PM Eastern Daylight Time

Video
Article thumbnail News Release

Rakovina Therapeutics shares new kt-3000 data at American Association of Cancer Research event

Rakovina Therapeutics Inc

Rakovina Therapeutics chief scientific officer Mads Daugaard joined Steve Darling from Proactive with news that the company has shared new data at the American Association of Cancer Research meeting in Orlando, Florida. Daugaard tells Proactive the data describes the progress of the company’s kt-3000 drug development program. The data shows the kt-3000 prototype lead candidate exhibits higher PARP-1 versus PARP-2 selectivity compared to the FDA-approved PARP inhibitor, olaparib. Daugaard also says the kt-3000 lead candidate effectively reduced lung metastases in mice inoculated with Ewing sarcoma tumor cells. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 24, 2023 12:21 PM Eastern Daylight Time

Video
Article thumbnail News Release

Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting

Context Therapeutics

Context Therapeutics CEO Marty Lehr joins Proactive's Natalie Stoberman to discuss CTIM-76 preclinical data presented at the American Association for Cancer Research (AACR) Annual Meeting 2023. Lehr noted the latest CTIM-76 bispecific antibody data and developments were shared with investors and colleagues as Context prepares for an Investigational New Drug application filing in early 2024. CTIM-76 is a Claudin 6 (CLDN6) X CD3 bispecific antibody currently in preclinical development that is capable of binding to tumor cells expressing CLDN6 and stimulating intra-tumoral T cells by the CD3 arm that is designed to be activated only upon tumor engagement while silent elsewhere. CLDN6 is expressed in multiple solid tumors, including ovarian, lung, and testicular cancers. The R&D webinar presentation can be found here: https://ir.contexttherapeutics.com/static-files/9377e4ba-bce3-4daa-a4f5-708b6a7c61dc Contact Details Proactive Investors USA +1 347-449-0879 na-editorial@proactiveinvestors.com

April 24, 2023 12:01 PM Eastern Daylight Time

Video
Article thumbnail News Release

Tonix Pharmaceuticals TNX-1500 monoclonal antibody published in American Journal of Transplantation

Tonix Pharmaceuticals

Tonix Pharmaceuticals CEO Seth Lederman joins Proactive's Natalie Stoberman to share the findings of two publications in the American Journal of Transplantation that demonstrate how the company's TNX-1500 monoclonal antibody product candidate aided in the prevention of organ rejection for kidney and heart transplants. Lederman says these animal studies found that TNX-1500 retains activity to prevent rejection and preserve graft function. He adds that Tonix expects to start a first-in-human Phase 1 study in the second quarter of 2023 of TNX-1500 for prophylaxis of organ rejection in adult patients receiving a kidney transplant. Contact Details Proactive Studio +1 347-449-0879 na-editorial@proactiveinvestors.com

April 24, 2023 11:34 AM Eastern Daylight Time

Video
Article thumbnail News Release

American Diversified Holdings Corporation Enters CBD Market with Leading Partners

American Diversified Holdings Corp.

McapMediaWire -- American Diversified Holdings Corporation (OTC: ADHC) is pleased to announce today that the company, through its brands UNIVERSAL WELLNESS and Amazon vendor RollsChoice™, has reached a comprehensive alliance with GGII's leading group of companies in the CBD and Hemp sector. ADHC's agreement with Green Globe International Group (OTC: " GGII "), Hempacco (NASDAQ: " HPCO ") and GGII's operating subsidiary Green Star Labs provides for a broad range of services and interrelated business activity. The synergies of this alliance are derived from the cross-branding of the products. The GGII/HEMPACCO/GREENSTAR group has entered into this alliance with ADHC and will collaborate as outlined below: Formulation, manufacturing, private label, inventory management, packaging and shipment logistics with be provided by Green Star Labs under the Universal Wellness and RollsChoice™ Jointly design a line of CDB, Dietary Supplements and Cosmetic products to be offered through ADHC' e-commerce platform www.UniversalWellnessShop.com Introduce and negotiate endorsement agreements with social media influencers and noted HipHop/Rap luminaries. Hempacco currently has relationships deals with Snoop Dogg Brands, rap artist Rick Ross, Hemp Hop Smokables and Cheech and Chong, Hemp Cigarettes. Parties have agreed to a financial partnership including share issuances, line of credit for product inventory, capital formation, and addition of future management. Parties have agreed to assess the development of ADHC existing brand and future products under development, including products sold under the of cannabis adhesive pens and lifestyle and CBD products. This alliance is set to springboard ADHC'S branded products into the rapidly growing CDB market sector. A recent report by Market Research Future (MRFR) indicated the CDB market is expected to reach over $59 billion by 2030 an 18% CAGR. This alliance is set to springboard ADHC'S branded products into the rapidly growing CDB market sector. A recent report by Market Research Future (MRFR) indicated the CDB market is expected to reach over $59 billion by 2030 an18% CAGR. See: Cannabidiol (CBD) Market Size Worth USD 59.3 Billion by (globenewswire.com) "This alliance with ADHC's Universal Wellness and RollsChoice ™ brands is a great opportunity for us to build revenues with a valued partner", commented Sandro Piancone, CEO of GGII and HPCO, "We look forward to hitting the ground running for a long term mutually beneficial alliance that enables us to sell products that have the attributes and features that represent the best parts of each brand." "The GGII/HPCO team is truly brilliant alliance partner for ADHC, we can now focus on pushing our brands to the forefront of the CBD and Cannabis markets with a manufacturing and brand building partner that is a dream come true for our shareholder", commented ADHC management. About Hempacco (NASDAQ: HPCO ) Hempacco Co., Inc.'s goal is Disrupting Tobacco's™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brand. Hempacco's operating segments include: Manufacturing of smokables, hemp rolling paper, and cannabinoid sticks Smokable technology development The Real Stuff™ brand of functional smokables and rolling paper Cheech and Chong Hemp Cigarettes and Hemp Hop Smokables with Rick Ross Snoop Dogg Joint Venture of Hemp-Derived Products Learn more at www.hempacco.com. Order products at www.realstuffsmokables.com. About HempBox Vending HempBox Vending offers a kiosk solution for smart vending technology to sell quickly moving consumer goods, including but not limited to nutraceuticals, CBD, hemp, herb, and spice smokables. About Green Globe International, Inc. (OTC: GGII ): Green Globe International is a Fast-Moving Consumer Goods incubator and holding company of intellectual property, products, and companies that better people's lives by helping them feel and look better inside and out. Green Globe International ( GGII ) owns or has interests in several brands and companies including; Green Star Labs, Inc., changing how people feel about themselves inside and out with nutritional supplements, CBD, and beauty products, and hemp CBD cigarette and rolling paper manufacturer Hempacco Co. Inc., (NASDAQ: HPCO ) Disrupting Tobacco's™ $1 Trillion tobacco industry, with its subsidiaries and joint ventures including HempBox Vending, Inc. a vending and advertising company, Hempacco Paper Company, Inc., producing The Real Stuff Hemp Smokables and hemp paper smoking products like blunts, tubes, and cones, Cali Vibes, Inc. manufacturing cannabinoid cigarettes, HempHop Smokables, Inc., partnering with music producer and rapper Rick Ross, Cheech and Chong Smokables, Inc. delivering cannabinoid Hemp CBD cigarettes to consumers with Cheech and Chong as partners, StickIt USA, Inc., manufacturing a line of cannabinoid sticks, and HPDG, LLC a partnership with Snoop Dogg to develop hemp-derived consumer goods products. Green Globe International is publicly traded under the ticker symbol (OTC: GGII ). It continues to look for best-in-class companies, products, and patents to create Fast Moving Consumer Goods and channels to sell them, including retail automation and advertising platforms. ABOUT ADHC/UNIVERSAL WELLNESS/ROLLS CHOICE: ADHC is a publicly traded holding company trading under the ticker symbol (OTC: ADHC ). ADHC is currently developing two web-based branded businesses. Universal Wellness (UWS) is a wellness and lifestyle e-commerce site focused on providing innovative products, news, and the latest healthcare developments RollsChoice™ is a Southern California-based manufacturer, distributor, and e-commerce company selling an all-natural Adhesive Glue and application device sold off AMAZON.com and through its own website. The Pens come in 1 ml, 2 ml, and 100 pen packs. RollsChoice™ has significant brand awareness in the cannabis industry and boasts over 80,000 followers on Twitter and Instagram. Recently over 12,000 adhesive pens have been manufactured and sold. The adhesive is made of Food Grade Premium ingredients. RollsChoice™ Adhesive Pen is Flavorless, Colorless, Tasteless and Stainless. It is used to seal cannabis and tobacco rolled products including blunts, joints, cigars and hand rolled cigarettes in a sterile manner allowing for long lasting adhesive qualities. The proprietary brush tip pen is recommended for precision. RC sells direct to smoke shops, dispensaries and direct to consumers through its e-commerce site. Through the companies multi year history sales over 12,000 adhesive pens and been manufactured and sold by RollsChoice™. see (USPTO ROLLS CHOICE 97278083). RollsChoice™ has over 80,000 social media followers which will be introduced to ADHC social media platforms on Twitter, Instagram, Facebook, and TikTok. This relationship will establish a very strong presence providing brand awareness to potential customers and shareholders as the Universal Wellness/Rolls Choice business relationship develops and revenues grow. Website: www.Rollsschoiceadhesive.com Email: rollschoicerepresentative619@gmail.com Twitter: https://www.twitter.com/rollschoice Instagram: https://www.instagram/rollschoicadhesivepen In addition to the adhesive pen, RC has numerous other cannabis related products being developed that will be introduced as a result of this Acquisition agreement. Shareholders, customers, and other interested parties can find product offerings by searching AMAZON under these UPC codes: B0B1BTNW4Q and B0B2R3D2TS or clicking this link: https://a.co/d/3ONJjG Amazon.com: Rolls Choice™ Adhesive Pen (25, 1ml) RollsChoice™ has a pending trademark with the USPTO under application number 972978083. LITIGATION UPDATE ADHC has filed suit in The Eight Judicial Circuit Court, Clark County, Nevada case Number A-21-843-670, seeking the cancellation of 330,000,000 (330 MM) shares of common stock. On January 6, 2023, the court granted the motion for default. It is anticipated that the court will be issuing the formal order soon on a scheduled hearing date of April 17th, 2023. Granting the default judgment is the final legal step before all litigation is resolved. Currently, ADHC capitalization structure is as follows: Shares Outstanding: 1.1 billion Shares Restricted: 600 million Shares in the Float: 504 million Investor Contact: Ernest Remo Chairman/CEO EMAIL: ernestremo@san.rr.com Tel: 858-259-4534 TWITTER: @ADHCManagement. This Twitter page is the only official Twitter page for ADHC. Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and uncertainties that may cause our actual results to be materially different from the performance or achievements expressed. You should not place undue reliance on these statements since they involve known and unknown risks, in some cases, beyond our control. SAFE HARBOR These statements relate to future events or future financial performance, involving known and unknown risks and uncertainties that may cause our actual results to be materially different to performance or achievements expressed. You should not place undue reliance on these statements, since they involve known and unknown risks. Any forward-looking statements reflect the current view with respect to future events and subject to uncertainties Contact Details Ernest Remo ernestremo@san.rr.com Company Website http://www.universalwellnessshop.com/

April 24, 2023 06:00 AM Eastern Daylight Time

Article thumbnail News Release

Arecor Therapeutics has "a strong basis to accelerate" growth strategy

Arecor Therapeutics PLC

Arecor Therapeutics PLC (AIM:AREC) CEO Sarah Howell speaks to Thomas Warner from Proactive after releasing preliminary full-year results for 2022. She gives her take on the highlights from last year before going on to lay out what investors can expect from the business during 2023. Howell says that Arecor has a "strong basis to accelerate" its growth strategy and "plenty to look forward to." Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 24, 2023 03:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Faron Pharmaceuticals "confirms promising results from first cohort"

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Chief Medical Officer Marie-Louise Fjällskog speaks to Proactive about progress on the clinical stage biopharmaceutical company's BEXMAB study. Fjällskog "confirms promising results from the first cohort" and highlights plans to go to the FDA "very soon" to share the company's plan for "getting into an accelerated approval pathway". Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 24, 2023 03:00 AM Eastern Daylight Time

Video
Article thumbnail News Release

Kromek Group announces two "key contract" wins

Kromek Group PLC

Kromek Group PLC (AIM:KMK) CEO Arnab Basu speaks to Thomas Warner from Proactive following a week of announcements that include two "key contract" wins and a Q3 trading update. Basu said the contracts validate the growth story at Kromek, which had been working for several years to build relationships with OEMs. In its Q3 trading update, Kromek recorded a 50% YoY growth in revenues. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 24, 2023 03:00 AM Eastern Daylight Time

Video
1 ... 116117118119120 ... 290